Drawing for XERISTAR

USPTO serial 76387718

XERISTAR

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
JENKINS JR, CHARLES L
Law office
INTENT TO USE UNIT

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with XERISTAR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005pharmaceutical preparations, namely pharmaceutical preparations for the treatment and prevention of blood disorders, cancer/oncology, cardiovascular diseases, central nervous systems diseases and disorders, dermatological disorders, diabetic neuropathy, endocrine disorders, gastrointestinal disorders, hormonal diseases and disorders, immunological, bacterial, viral and fungal disorders, infectious diseases, inflammation and inflammatory diseases, musculoskeletal disorders, neurodegenerative disorders, neurological disorders, obesity, ophthalmologic conditions and diseases, pain, peripheral nervous system diseases and disorders, reproductive disorders, sexual dysfunction, sepsis, urological disordersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
May 11, 2005MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 11, 2005ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 3, 2004EX3GSOU EXTENSION 3 GRANTED—
May 28, 2004CFITCASE FILE IN TICRS—
May 25, 2004EXT3SOU EXTENSION 3 FILED—
May 25, 2004EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 3, 2003EX2GSOU EXTENSION 2 GRANTED—
Nov 21, 2003EXT2SOU EXTENSION 2 FILED—
Nov 21, 2003EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 9, 2003EX1GSOU EXTENSION 1 GRANTED—
Jun 23, 2003EXT1SOU EXTENSION 1 FILED—
Jun 23, 2003MAILPAPER RECEIVED—
Jan 7, 2003NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 15, 2002PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 25, 2002NPUBNOTICE OF PUBLICATION—
Jul 24, 2002CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 24, 2002DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance